In Meraouna et al.'s study, the failure-free survival rate was 66% at 3 years of follow-up. Regarding treatment-related morbidities, 12.3% of patients experienced grade 3 genitourinary (GU) toxicity, ...

Was it simply a fluke that he kept treating strikingly young patients? Or was his practice one tiny data point in a larger trend? He found his answer after sifting through national health data: ...

A groundbreaking study has uncovered how specific genetic mutations influence cancer treatment outcomes -- insights that could help doctors tailor treatments more effectively. The largest study of its ...

The prognosis of patients with gastrointestinal stromal tumors is significantly impacted by gastrointestinal bleeding.

Previse, a gastrointestinal health company, announced a newly published study in the American Journal of Gastroenterology, ...

For patients undergoing prostate radiotherapy, acute toxicity is associated with late toxicity and decrement in qua ...

Background Cancer, a major global health challenge, not only threatens lives but also imposes severe financial burdens, known ...

In patients with residual disease after curative resection of colorectal cancer, Lonsurf showed a numerical improvement in ...

GEM Hospital's 'GEM Oncoshield' initiative offers free second opinions and advanced treatments for cancer patients nationwide in February.

Key opinion leaders explores the management of gastrointestinal side effects in patients on osimertinib, focusing on ...

Marwan G. Fakih, MD, explains the implications of the findings from the phase 2 trial of balstilimab plus botensilimab for ...

Kolkata: A 72-year-old female pancreatic cancer survivor, whose stomach was ripped by an intestinal mesh implanted to prevent ...